Physician profile
Deepa Kapoor
NPI 1629198627
$996.89
in general payments reported to CMS, 2019-2025
12 companies · $300 in 2025
The $300 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $274 · 2022: $274 · 2023: $128 · 2024: $21.00 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $448.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $175.80 | 2025 | Assure Wcd |
| Amgen INC. | $130.65 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $118.16 | 2021-2022 | |
| Abbott Laboratories | $117.87 | 2023-2025 | Jot Dx, Aveir |
| Merck Sharp & Dohme LLC | $108.79 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $85.80 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $75.08 | 2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $58.06 | 2021-2022 | |
| Atricure, INC. | $40.38 | 2021 | |
| Medtronic, INC. | $32.45 | 2023 | Micra |
| Cvrx, INC. | $29.70 | 2021-2025 | Barostim Neo System |
| Abiomed | $24.15 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepa Kapoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.